BR8302502U - Packaging, or drug kit, or facilitative presentation of drug administration by individuals in prevention and / or treatment of atherosclerotic disease - Google Patents
Packaging, or drug kit, or facilitative presentation of drug administration by individuals in prevention and / or treatment of atherosclerotic diseaseInfo
- Publication number
- BR8302502U BR8302502U BR8302502U BR8302502U BR8302502U BR 8302502 U BR8302502 U BR 8302502U BR 8302502 U BR8302502 U BR 8302502U BR 8302502 U BR8302502 U BR 8302502U BR 8302502 U BR8302502 U BR 8302502U
- Authority
- BR
- Brazil
- Prior art keywords
- treatment
- individuals
- packaging
- drug
- presentation
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61J—CONTAINERS SPECIALLY ADAPTED FOR MEDICAL OR PHARMACEUTICAL PURPOSES; DEVICES OR METHODS SPECIALLY ADAPTED FOR BRINGING PHARMACEUTICAL PRODUCTS INTO PARTICULAR PHYSICAL OR ADMINISTERING FORMS; DEVICES FOR ADMINISTERING FOOD OR MEDICINES ORALLY; BABY COMFORTERS; DEVICES FOR RECEIVING SPITTLE
- A61J1/00—Containers specially adapted for medical or pharmaceutical purposes
- A61J1/03—Containers specially adapted for medical or pharmaceutical purposes for pills or tablets
- A61J1/035—Blister-type containers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61J—CONTAINERS SPECIALLY ADAPTED FOR MEDICAL OR PHARMACEUTICAL PURPOSES; DEVICES OR METHODS SPECIALLY ADAPTED FOR BRINGING PHARMACEUTICAL PRODUCTS INTO PARTICULAR PHYSICAL OR ADMINISTERING FORMS; DEVICES FOR ADMINISTERING FOOD OR MEDICINES ORALLY; BABY COMFORTERS; DEVICES FOR RECEIVING SPITTLE
- A61J7/00—Devices for administering medicines orally, e.g. spoons; Pill counting devices; Arrangements for time indication or reminder for taking medicine
- A61J7/04—Arrangements for time indication or reminder for taking medicine, e.g. programmed dispensers
Landscapes
- Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Vascular Medicine (AREA)
- Urology & Nephrology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medical Preparation Storing Or Oral Administration Devices (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicinal Preparation (AREA)
Abstract
"EMBALAGEM. OU KIT DE MEDICAMENTOS. OU APRESENTAçãO FACILITADORA DA ADMINISTRAçãO DE MEDICAMENTOS POR PARTE DE INDIVìDUOS EM PREVENçãO E/OU TRATAMENTO DA DOENçA ATEROSCLERóTICA".O presente Modelo de Utilidade trata de embalagem, ou kit de medicamentos, ou apresentação facilitadora da administração de medicamentos por parte de indivíduos em tratamento caracterizados por compreender em cada cartela, cartucho, blíster ou similar, um ou mais agentes antiplaquetários, antiinflamatórios ou apresentando atividade fibrinolítica positiva conjuntamente com um ou mais agentes capazes de melhor o perfil lipídico do sangue, e opcionalmente um ou mais medicamentos conhecidos do homem da técnica para esse tipo de tratamento, apresentados de forma didática, clara e segura, orientações informações ao paciente quanto à natureza ou tipo do princípio ativo, dosagem, quantidade de unidades de medicamentos, período do dia a ser tomada, assim como periodicidade do tratamento, ou outras informações, ou ainda segundo as FIGURAS 1 E 2."PACKAGING. OR MEDICINAL PRODUCTS KIT. OR EASY PRESENTATION OF MEDICINAL PRODUCTS ADMINISTRATION AND / OR TREATMENT OF INDIVIDUALS." medicaments by subjects in treatment characterized in that each card, cartridge, blister or the like comprises one or more antiplatelet, anti-inflammatory or positive fibrinolytic activity together with one or more agents capable of improving the blood lipid profile, and optionally one. or more drugs known to the man of the art for this type of treatment, presented in a didactic, clear and safe manner, guidance to the patient as to the nature or type of active ingredient, dosage, number of units of medication, time of day to be taken. as well as the periodicity of treatment, or the other information, or according to FIGURES 1 AND 2.
Priority Applications (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
BR8302502U BR8302502U (en) | 2003-06-10 | 2003-06-10 | Packaging, or drug kit, or facilitative presentation of drug administration by individuals in prevention and / or treatment of atherosclerotic disease |
PCT/BR2004/000089 WO2004108056A2 (en) | 2003-06-10 | 2004-06-09 | Packing, or kit of medicaments, or facilitating presentation of administering of medicaments on the part of individuals under preventive situation and/or treatment of the atherosclerosis disease |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
BR8302502U BR8302502U (en) | 2003-06-10 | 2003-06-10 | Packaging, or drug kit, or facilitative presentation of drug administration by individuals in prevention and / or treatment of atherosclerotic disease |
Publications (1)
Publication Number | Publication Date |
---|---|
BR8302502U true BR8302502U (en) | 2005-04-19 |
Family
ID=38895611
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
BR8302502U BR8302502U (en) | 2003-06-10 | 2003-06-10 | Packaging, or drug kit, or facilitative presentation of drug administration by individuals in prevention and / or treatment of atherosclerotic disease |
Country Status (2)
Country | Link |
---|---|
BR (1) | BR8302502U (en) |
WO (1) | WO2004108056A2 (en) |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6235311B1 (en) * | 1998-03-18 | 2001-05-22 | Bristol-Myers Squibb Company | Pharmaceutical composition containing a combination of a statin and aspirin and method |
US20020045184A1 (en) * | 2000-10-02 | 2002-04-18 | Chih-Ming Chen | Packaging system |
US20030013688A1 (en) * | 2001-06-21 | 2003-01-16 | Rene Belder | Synergistic combination of pravastatin and aspirin and method |
US6576256B2 (en) * | 2001-08-28 | 2003-06-10 | The Brigham And Women's Hospital, Inc. | Treatment of patients at elevated cardiovascular risk with a combination of a cholesterol-lowering agent, an inhibitor of the renin-angiotensin system, and aspirin |
-
2003
- 2003-06-10 BR BR8302502U patent/BR8302502U/en not_active Application Discontinuation
-
2004
- 2004-06-09 WO PCT/BR2004/000089 patent/WO2004108056A2/en active Application Filing
Also Published As
Publication number | Publication date |
---|---|
WO2004108056A2 (en) | 2004-12-16 |
WO2004108056A3 (en) | 2008-01-10 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Boateng | Drug delivery innovations to address global health challenges for pediatric and geriatric populations (through improvements in patient compliance) | |
ES2683042T3 (en) | Treatment of symptoms associated with gastroparesis in women | |
Herson et al. | Magical thinking and imipramine poisoning in two school-aged children | |
ES2139842T3 (en) | USE OF MELATONIN TO TREAT PATIENTS WHO SUFFER DRUG DEPENDENCE. | |
BR8302502U (en) | Packaging, or drug kit, or facilitative presentation of drug administration by individuals in prevention and / or treatment of atherosclerotic disease | |
Ezechukwu et al. | Drug Treatment Of Common Childhood Symptoms In Nnewi South Eastern Nigeria: What Mothers Do? | |
BR8300543U (en) | Packaging, or drug kit, or patient-friendly presentation of drug administration | |
KR200255738Y1 (en) | Aid box for taking prescribed medicine | |
Zidd et al. | Pediatric ingestion of lamotrigine | |
Hartman et al. | Influence of advertising on the assortment of OTC cold medications | |
JP2004526791A5 (en) | ||
Cohen | Double trouble | |
Stewart | Preventing medication errors [Ask your pharmacist] | |
Syrup | Allanhist PDX Syrup and Oxtellar XR | |
Strength | Diphenhydramine Oral Solution and Mucinex DM Maximum Strength | |
Strength | Loxapine Capsules and Mucinex DM Maximum Strength | |
Tablets | Norvir Tablets and Poly-Tussin DM | |
Gever | Drug challenge | |
Fund | Tablets | |
Oral | Ambien Oral and Mucinex Fast-Max Severe Cold | |
Cold | Butisol Sodium and Pedia Care Multi-Symptom Cold | |
Niva-Hist | Niva-Hist DM and Riomet Oral Suspension | |
WO2003013522A1 (en) | Preventives/remedies for cholinergic neuropathy | |
FORTE | Glenmax PEB DM FORTE and Promethazine Syrup | |
Tablets | Metformin Extended-Release Tablets and Niva-Hist DM |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
B25D | Requested change of name of applicant approved |
Owner name: MEDLEY INDUSTRIA FARMACEUTICA LTDA (BR/SP) Free format text: ALTERADO DE: MEDLEY S.A. INDUSTRIA FARMACEUTICA |
|
B07A | Technical examination (opinion): publication of technical examination (opinion) | ||
B09B | Decision: refusal |
Free format text: INDEFIRO O PEDIDO DE ACORDO COM O(S) ARTIGO(S) 9O E 14 DA LPI |
|
B09B | Decision: refusal |
Free format text: MANTIDO O INDEFERIMENTO UMA VEZ QUE NAO FOI APRESENTADO RECURSO DENTRO DO PRAZO LEGAL. |